Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Christine K. Bailey"'
Autor:
Christine K. Bailey, Stephen Caltabiano, Alexander R. Cobitz, Chun Huang, Kelly M. Mahar, Vickas V. Patel
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-12 (2019)
Abstract Background Daprodustat is a hypoxia-inducible factor-prolyl hydroxylase inhibitor currently being investigated as a treatment for anemia of chronic kidney disease (CKD) in both dialysis and nondialysis patients. In clinical studies to date,
Externí odkaz:
https://doaj.org/article/27bc2670a74349538c5d727bfabca1f7
Autor:
Daniel W. Coyne, Ajay K. Singh, Renato D. Lopes, Christine K. Bailey, Tara L. DiMino, Chun Huang, Jeffrey Connaire, Anjay Rastogi, Sung-Gyun Kim, Marcelo Orias, Sapna Shah, Vickas Patel, Alexander R. Cobitz, Christoph Wanner
Publikováno v:
Clinical Journal of the American Society of Nephrology. 17:1325-1336
Daprodustat is a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) being investigated for the treatment of anemia of CKD. In this noninferiority trial, we compared daprodustat administered three times weekly with epoetin alfa (epoetin)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2deecb99dbef179987732f8195919778
https://doi.org/10.2215/cjn.00550122
https://doi.org/10.2215/cjn.00550122
Autor:
Gregorio Obrador, Iain Macdougall, Kirsten Johansen, Vivekanand Jha, Ricardo Correa-Rotter, Lucia Del Vecchio, Aleix Cases Amenos, Michele Robertson, Steve Mallett, Christine K. Bailey, Alexander Cobitz, Ajay K. Singh
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Preliminary analyses suggest that absolute haemoglobin (Hb) values and rapid Hb changes may be associated with adverse outcomes in patients with anaemia of chronic kidney disease (CKD) treated with erythropoiesis-stimulating agent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b615065b3e6e18526d07dc5cae23c628
https://doi.org/10.1093/ndt/gfac072.016
https://doi.org/10.1093/ndt/gfac072.016
Autor:
Ajay K. Singh, Iain Macdougall, Kirsten Johansen, Vivekanand Jha, Ricardo Correa-Rotter, Lucia Del Vecchio, Aleix Cases Amenos, Michele Robertson, Steve Mallett, Christine K. Bailey, Alexander Cobitz, Gregorio Obrador
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Rapid changes in haemoglobin (Hb) following treatment with erythropoiesis-stimulating agents (ESAs) in patients with anaemia of chronic kidney disease (CKD) have been suggested to be associated with adverse outcomes [1–3]. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e3897d9f716b7623d17b0f665b56cd1
https://doi.org/10.1093/ndt/gfac072.017
https://doi.org/10.1093/ndt/gfac072.017
Autor:
Alexander R. Cobitz, Christine K Bailey, Kelly M. Mahar, Vickas V. Patel, Stephen Caltabiano, Chun Huang
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-12 (2019)
BMC Nephrology
BMC Nephrology
Background Daprodustat is a hypoxia-inducible factor-prolyl hydroxylase inhibitor currently being investigated as a treatment for anemia of chronic kidney disease (CKD) in both dialysis and nondialysis patients. In clinical studies to date, daprodust
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d09fc1afa7cb3093c224262a4a6b52d3
http://link.springer.com/article/10.1186/s12882-019-1547-z
http://link.springer.com/article/10.1186/s12882-019-1547-z
Autor:
Dagmar Pospisilova, Christine K Bailey, Thirachit Chotsampancharoen, James B. Bussel, Patcharee Komvilaisak, Susanne Holzhauer, Lisa M Marcello, Elena K. Donyush, John D. Grainger, Ugo Ramenghi, Franco Locatelli, Geoffrey W. Chan, Karen Chagin, Richard S. Lemons, Nongnuch Sirachainan, Guillermo Drelichman, Darintr Sosothikul, Vladimir Lebedev, Malini Iyengar, Bunchoo Pongtanakul, Kalpana Bakshi, Dickens Theodore
Publikováno v:
The Lancet. 386:1649-1658
Summary Background The thrombopoietin receptor agonist eltrombopag has been shown to be safe, tolerable, and effective for adults with chronic immune thrombocytopenia. We aimed to investigate the safety and efficacy of eltrombopag for children with c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f56e2aa9aa8b0f253582612cc827b55
https://doi.org/10.1016/s0140-6736(15)61107-2
https://doi.org/10.1016/s0140-6736(15)61107-2
Autor:
Lakshmanan Krishnamurti, Dickens Theodore, Julián Sevilla, Karen Chagin, John D. Grainger, Jenny M. Despotovic, Malini Iyengar, James B. Bussel, Koh B. Boayue, Lisa M Marcello, Kalpana Bakshi, Geoffrey W. Chan, Purificación García de Miguel, Philip Connor, Michèle David, Victor S. Blanchette, Michele P. Lambert, Christine K Bailey, Dana C. Matthews
Publikováno v:
The Lancet Haematology. 2:e315-e325
The oral thrombopoietin receptor agonist eltrombopag is approved for treatment of adults with chronic immune thrombocytopenia. In the PETIT trial, we aimed to investigate the efficacy and safety of eltrombopag in children with persistent or chronic i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00236ecc622616b3c923c215bb1bf8fb
https://doi.org/10.1016/s2352-3026(15)00114-3
https://doi.org/10.1016/s2352-3026(15)00114-3
Autor:
Dickens Theodore, Attilio Orazi, Maung M. Thein, Kalpana Bakshi, Russell K. Brynes, Paul Burgess, Christine K Bailey
Publikováno v:
American Journal of Hematology. 90:598-601
Thrombopoietin receptor agonists, which raise platelet counts in patients with chronic immune thrombocytopenia, may be associated with increases in bone marrow (BM) reticulin. Patients with chronic immune thrombocytopenia participating in the Eltromb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::896f2580fa51e552254ca7fcbfdd06ed
https://doi.org/10.1002/ajh.24011
https://doi.org/10.1002/ajh.24011
Publikováno v:
Journal of Religion and Health. 41:153-166
The purpose of this study was to test the effectiveness of a spiritually-based intervention in the alleviation of subsyndromal anxiety and minor depression in an elderly population. Twenty-two residents of six continuing care communities diagnosed wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40ff0d11bae59eaf4af10dd1382cd1cc
https://doi.org/10.1023/a:1015854226937
https://doi.org/10.1023/a:1015854226937
Autor:
Russell K, Brynes, Attilio, Orazi, Dickens, Theodore, Paul, Burgess, Christine K, Bailey, Maung M, Thein, Kalpana K, Bakshi
Publikováno v:
American journal of hematology. 90(7)
Thrombopoietin receptor agonists, which raise platelet counts in patients with chronic immune thrombocytopenia, may be associated with increases in bone marrow (BM) reticulin. Patients with chronic immune thrombocytopenia participating in the Eltromb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c2a1f775106610751b78a9dde91fe80b
https://pubmed.ncbi.nlm.nih.gov/25801698
https://pubmed.ncbi.nlm.nih.gov/25801698